J. Rataud et al., COMPARATIVE-STUDY OF VOLTAGE-SENSITIVE SODIUM-CHANNEL BLOCKERS IN FOCAL ISCHEMIA AND ELECTRIC CONVULSIONS IN RODENTS, Neuroscience letters, 172(1-2), 1994, pp. 19-23
This study evaluates the neuroprotective properties of some voltage-se
nsitive sodium channel blockers in a model of focal ischaemia. After c
urative treatment (0.5 and 24.5 h after insult), well known voltage-se
nsitive sodium channel blockers, phenytoin (2 x 100 mg/kg i.p.), carba
mazepine (2 x 50 mg/kg i.p.), lamotrigine (2 x 50 mg/kg i.p.) and RP 6
6055 (2 x 8 mg/kg i.p.) were found to protect rats against brain damag
e induced by occlusion of the middle cerebral artery, by 40%, 24%, 28%
and 44% respectively. These compounds were also active in protecting
both mice and rats against tonic convulsions induced by electroshock,
Intraperitoneal ED(50) values in mice and rats respectively were of 5.
2 and 12.5 mg/kg for phenytoin, 8.4 and 3.6 mg/kg for carbamazepine, 4
.4 and 3.1 mg/kg for lamotrigine, 3.9 and 0.22 mg/kg for RP 66055. In
contrast, lifarizine was totally devoid of activity in these three tes
ts. This study extends an accumulation of data in the literature point
ing to a therapeutic potential for voltage-dependent sodium channel bl
ockers which penetrate the blood brain barrier. Such compounds as phen
ytoin, carbamazepine, lamotrigine or RP 66055 may act at sodium channe
ls to prevent depolarization, inhibit release of neurotransmitters suc
h as glutamate and thus protects the cortex against cellular damage in
duced by focal ischaemia by both pre- and post-synaptic inhibition of
abnormal neurotransmission.